chr14-23382430-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PVS1_ModerateBS2
The NM_002471.4(MYH6):c.5794A>T(p.Lys1932Ter) variant causes a stop gained, splice region change. The variant allele was found at a frequency of 0.0000613 in 1,614,002 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. K1932K) has been classified as Uncertain significance.
Frequency
Consequence
NM_002471.4 stop_gained, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MYH6 | NM_002471.4 | c.5794A>T | p.Lys1932Ter | stop_gained, splice_region_variant | 38/39 | ENST00000405093.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MYH6 | ENST00000405093.9 | c.5794A>T | p.Lys1932Ter | stop_gained, splice_region_variant | 38/39 | 5 | NM_002471.4 | P1 | |
MYH6 | ENST00000651452.1 | n.1021A>T | splice_region_variant, non_coding_transcript_exon_variant | 2/3 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152134Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251478Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135912
GnomAD4 exome AF: 0.0000657 AC: 96AN: 1461868Hom.: 0 Cov.: 33 AF XY: 0.0000523 AC XY: 38AN XY: 727240
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152134Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74316
ClinVar
Submissions by phenotype
Hypertrophic cardiomyopathy 14 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 04, 2022 | This sequence change creates a premature translational stop signal (p.Lys1932*) in the MYH6 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 8 amino acid(s) of the MYH6 protein. This variant is present in population databases (rs763914096, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with structural heart defects (PMID: 28991257, 30293987). ClinVar contains an entry for this variant (Variation ID: 566642). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Dilated cardiomyopathy 1EE;C2750467:Hypertrophic cardiomyopathy 14;C3279790:Atrial septal defect 3;C3279791:Sick sinus syndrome 3, susceptibility to;C3495498:Hypertrophic cardiomyopathy 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Sep 20, 2021 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Feb 03, 2022 | PVS1_moderate - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 19, 2021 | The p.K1932* variant (also known as c.5794A>T), located in coding exon 36 of the MYH6 gene, results from an A to T substitution at nucleotide position 5794. This changes the amino acid from a lysine to a stop codon within coding exon 36. This variant has been reported in two individuals with congenital heart defects, both of whom were compound heterozygotes for additional MYH6 variants (Jin SC et al. Nat Genet, 2017 Nov;49:1593-1601; Alankarage D et al. Genet Med, 2019 05;21:1111-1120). This alteration occurs at the 3' terminus of theMYH6 gene, is not expected to trigger nonsense-mediated mRNAdecay, and only impacts the last 8 amino acids of the protein. The exact functional effect of this alteration is unknown. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at